| Stage | DOLE | % of rev | CTVA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.5B | 100.00% | $6.4B | 100.00% | CTVA ×2.55 |
| Gross profit | $195M | 7.81% | $3.7B | 57.39% | CTVA +49.6pp |
| Operating income | $47M | 1.90% | $1.8B | 28.01% | CTVA +26.1pp |
| Pre-tax income | $41M | 1.64% | $1.6B | 25.47% | CTVA +23.8pp |
| Net income | $35M | 1.41% | $1.2B | 18.26% | CTVA +16.9pp |
| Stage | DOLE | CTVA | Gap · A − B |
|---|---|---|---|
| Revenue | $2.5B100.00% | $6.4B100.00% | CTVA ×2.55 |
| Gross profit | 7.81%$195M | 57.39%$3.7B | CTVA +49.6pp |
| Operating income | 1.90%$47M | 28.01%$1.8B | CTVA +26.1pp |
| Pre-tax income | 1.64%$41M | 25.47%$1.6B | CTVA +23.8pp |
| Net income |
| 1.41%$35M |
| 18.26%$1.2B |
| CTVA +16.9pp |
No shared counterparties.